India's monsoon floods kill at least 22 people in the country's northeast
Landslides and flash flooding triggered by days of torrential monsoon rains in India's northeast have killed at least 22 people, officials said Saturday.
Five people, including three from a single family, were killed on Saturday when their homes were buried in a mudslide in Assam state's Guwahati city, an official flood bulletin said. In neighbouring Arunachal Pradesh state, which borders China, seven people were killed on Friday when their vehicle was swept away by floodwaters. Two others drowned in a separate incident in the state.
Eight people were killed in the states of Mizoram, Tripura and Meghalaya in the last 24 hours due to floods and mudslides brought on by the rains, according to official figures.
Meanwhile in Assam, authorities disconnected the electricity in several areas to reduce the risk of electrocution, state Chief Minister Himanta Biswa Sarma said. Heavy rains also led to flooding in many urban areas of Assam's capital city of Guwahati, leading to long power outages Friday night and prompting authorities to shut schools and colleges on Saturday.
India's weather agency has forecast more heavy rains in the region in the coming days.
India's annual June-September monsoon season offers respite from intense summer heat. But the rains that are crucial for crops planted during the season often cause extensive damage, particularly in the northeast, which is considered one of the most vulnerable regions to climate change.
Scientists say monsoons are becoming more erratic because of extreme weather and global warming, leading to frequent landslides and flash floods in India's Himalayan north.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
2 hours ago
- The Independent
Police officer fatally shoots person at Atlanta apartment complex
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging. At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story. The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it. Your support makes all the difference.
BBC News
4 hours ago
- BBC News
Superbugs thrive as access to antibiotics fails in India
It's a grim paradox, doctors the one hand, antibiotics are being overused until they no longer work, driving resistance and fuelling the rise of deadly superbugs. On the other hand, people are dying because they can't access these life-saving drugs.A new study by the non-profit Global Antibiotic Research and Development Partnership (GARDP) looked at access to antibiotics for nearly 1.5 million cases of carbapenem-resistant Gram-negative (CRGN) infections across eight major low- and middle-income countries, including India, Brazil and South Africa. CRGN bacteria are superbugs resistant to last-line antibiotics - yet only 6.9% of patients received appropriate treatment in the countries bore the lion's share of CRGN infections and treatment efforts, procuring 80% of the full courses of studied antibiotics but managing to treat only 7.8% of its estimated cases, the study in The Lancet Infectious Diseases journal reports. (A full drug course of antibiotics refers to the complete set of doses that a patient needs to take over a specific period to fully treat an infection.) Common in water, food, the environment and the human gut, Gram-negative bacteria cause infections such as urinary tract infections (UTIs), pneumonia and food poisoning. They can pose a serious threat to newborns and the elderly alike. Especially vulnerable are hospital patients with weakened immunity, often spreading rapidly in ICUs and proving difficult - and sometimes impossible - to treat. Treating carbapenem-resistant Gram-negative bacterial infections is doubly difficult because those bacteria are resistant to some of the most powerful antibiotics."These infections are a daily reality across all age groups," says Dr Abdul Gaffar, infectious disease consultant at Apollo Hospital in India's Chennai city. "We often see patients for whom no antibiotic works - and they die."The irony is cruel. While the world tries to curb antibiotic overuse, a parallel tragedy plays out quietly in poorer nations: people dying from treatable infections because the right drugs are out of reach. "For years, the dominant narrative has been that antibiotics are being overused, but the stark reality is that many people with highly drug-resistant infections in low- and middle-income countries are not getting access to the antibiotics they need," says Dr Jennifer Cohn, GARDP's Global Access Director and senior author of the 'blockbuster' drugs to take on deadly superbugsIndia facing a pandemic of antibiotics-resistant superbugsThe study examined eight intravenous drugs active against carbapenem-resistant bacteria - ranging from older antibiotics including Colistin to newer ones such as Ceftazidime-avibactam. Of the few available drugs, Tigecycline was the most widely used. Researchers blame the treatment gap on weak health systems and limited access to effective antibiotics. For example, only 103,647 full treatment courses were procured of Tigecycline across eight countries - far short of the 1.5 million patients who needed them, the study found. This highlighted a major shortfall in the global response to drug-resistant infections. What prevents patients with drug-resistant infections in India from getting the right antibiotics? Physicians point to multiple barriers - reaching the right health facility, getting accurate diagnostic tests, and accessing effective drugs. Cost remains a major hurdle, with many of these antibiotics priced far beyond the reach of poorer patients. "Those who can afford these antibiotics often overuse them; those who can't, don't get them at all," says Dr Gaffar. "We need a system that ensures access for the poor and prevents misuse by the well-to-do."To improve access, these drugs must be made more affordable. To prevent misuse, stronger regulation is key. "Ideally, every antibiotic prescription in hospitals should require a second sign-off - by an infection specialist or microbiologist," says Dr Gaffar. "Some hospitals do this, but most don't. With the right oversight, regulators can ensure this becomes standard practice."To fix the access problem and curb misuse, both smarter policies and stronger safeguards are essential, say researchers. But access alone won't solve the crisis - the pipeline of new antibiotics is drying up. The decline in antibiotic R&D - and the limited availability of existing drugs - is a global bears one of the world's heaviest burdens of antimicrobial resistance (AMR), but it may also hold the key to combating it - both at home and globally, researchers say."India is also one of the largest markets for new antibiotics and can successfully advocate for the development and access of new antibiotics," says Dr Cohn. With a strong pharmaceutical base, the country is emerging as a hub for AMR innovation, from promising new antibiotics to advanced Cohn says India can strengthen its antibiotic response by generating local data to better estimate needs and pinpoint gaps in the care pathway. This would allow for more targeted interventions to improve access to the right drugs. Innovative models are already emerging - Kerala state, for instance, is using a "hub-and-spoke approach" to support lower-level facilities in managing serious infections. Coordinated or pooled procurement across hospitals or states could also reduce the cost of newer antibiotics, as seen with cancer drug programs, researchers access to the right antibiotics, modern medicine begins to unravel - doctors risk losing the ability to safely perform surgery, treat complications in cancer patients, or manage everyday infections. "As an infectious disease doctor, I see appropriate use as one part - but only one part - of access," says Dr Gaffar. "When we get new antibiotics, it's important to save them on one hand - and save them for right patients." Clearly, the challenge is not just to use antibiotics wisely, but to ensure they reach those who need them most.
BBC News
4 hours ago
- BBC News
Punjab Kings set up IPL final against RCB
Indian Premier League, Qualifier 2, AhmedabadMumbai Indians 203-6 (20 overs): Suryakumar 44 (26), Varma 44 (29); Azmatullah 2-43Punjab Kings 207-5 (19 overs): Shreyas 87* (41), Wadhera 48 (29); Ashwani 2-55Punjab Kings won by five wicketsScorecard Punjab Kings captain Shreyas Iyer hit a sparkling unbeaten 87 to lead his side to their first Indian Premier League final in 11 years with victory over Mumbai 204 to win, Shreyas clattered eight sixes in his 41-ball knock, smacking Ashwani Kumar into the stands to seal a five-wicket win with an over to the match started over two hours late because of rain in Ahmedabad, Mumbai posted 203-6 in their 20 overs, with Tilak Varma and Suryakumar Yadav both scoring 44 and Jonny Bairstow making 38 off 24 will meet Royal Challengers Bengaluru in Tuesday's final, also taking place at the Narendra Modi Stadium.A new IPL champion will be crowned, with both sides having never won the tournament. "I love such big occasions," said player of the match Shreyas."I always say to myself and to my colleagues in the team that the bigger the occasion, the calmer you are, you get the big results." Punjab won the toss and elected to bowl before the rain arrived, although no overs were play eventually started, Australia all-rounder Marcus Stoinis removed India opener Rohit Sharma for just eight, before Varma and Bairstow combined for 51 strong partnership worth 72 between Varma and Suryakumar put Mumbai in a decent position before both fell in the space of three Naman Dhir's 37 off 18 balls boosted the five-time champions to a challenging reply, Australia wicketkeeper Josh Inglis sparked Punjab with 38 off 21, including 20 off one over from India fast bowler Jasprit Mumbai hit back as captain Hardik Pandya removed Inglis and were marginal favourites when Nehal Wadhera fell for 48, with Kings needing 48 off 26 Shreyas kept his side in contention and, requiring 23 runs off the last two overs, he flicked the switch to smash four sixes in the 19th over in a clinical final is a repeat of the first qualifier match, in which RCB thrashed Kings by eight sides scored 19 points in the group stage, with Kings narrowly topping the table on net-run were beaten by Kolkata Knight Riders in their only previous final appearance in 2014, while RCB have lost the showpiece in 2009, 2011 and 2016.
